OR WAIT null SECS
August 12, 2022
Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity
August 10, 2022
Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity
August 02, 2022
Division will operate under SCHOTT Pharma AG & Co. KGaA
July 27, 2022
CDMO’s new project focuses on addressing needs in oncology sector
July 21, 2022
New property is valued at $323 million
July 20, 2022
Center will feature a $1.4 billion investment plan
July 12, 2022
Production capacity for the contract manufacturer is expected to more than triple
July 06, 2022
Will benefit CDMO’s Denmark and Texas locations
With a cost of approximately $514 million, expected completion is 2026
July 01, 2022
Cheshire facility will offer plasmid DNA production, CGT development